68 filings
Page 2 of 4
8-K
os0alxdsa2w61a lkv
7 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:15pm
8-K
ayzw rh4j2s96mgvbda
30 Mar 23
Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial Results
4:06pm
8-K
0gvq5ao
13 Mar 23
Regulation FD Disclosure
6:08am
8-K
jh5 7my6zmf9qn
20 Jan 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
3c0bugi5dfhg96fi99t2
12 Jan 23
Biora Therapeutics Receives Pre-IND Feedback from FDA and Provides Update on Key Programs for 2023
6:06am
8-K
qnuw594tzcsd9pf
9 Jan 23
Material Modifications to Rights of Security Holders
4:02pm
8-K
rdizesxcnva 58330
30 Dec 22
Material Modifications to Rights of Security Holders
9:01am
8-K
wkdr6 9zn7pj
19 Dec 22
Submission of Matters to a Vote of Security Holders
4:20pm
8-K
a1xp8a18
9 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
sozo9aw7wo4civmq k5
28 Nov 22
Amendments to Articles of Incorporation or Bylaws
4:06pm
8-K
o2qg8 stgem
23 Nov 22
Entry into a Material Definitive Agreement
4:06pm
8-K
5eilz4 j3
14 Nov 22
Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
5:24pm
8-K
abbmz zwj
10 Nov 22
Material Modifications to Rights of Security Holders
4:07pm
8-K
1zs vksiy74z4wtt
9 Nov 22
Entry into a Material Definitive Agreement
4:50pm
8-K
9s1ra zjbo
15 Aug 22
Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results
4:18pm
8-K
qt90g k2zs8hzxdp540d
15 Jun 22
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
sdwmgs8dps5yudx
10 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
h6wks5essy
10 May 22
Biora Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results
4:07pm
8-K
vi0lma0a0be 7c7sy6e3
27 Apr 22
Amendments to Articles of Incorporation or Bylaws
4:09pm
8-K
9u3r6 8n5
28 Mar 22
Progenity Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:05pm